Skip to main content
Log in

Development of phenotypic resistance to direct lethal miconazole action by Candida albicans entering stationary phase

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

In the late logarithmic or very early stationary phase of the growth cycle, yeast cells of Candida albicans undergo a shift from susceptibility to resistance to the direct lethal action of miconazole. Regulation of this phenotypic shift was examined. Experiments based on viable count determinations and the construction of time-kill curves showed that reestablishment of resistance is independent of both pH and the attainment of some critical viable cell density. However, it was found that development of resistance requires the continued availability of an appropriate energy source toward the end of exponential growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beggs WH. Requirement for nonprotonated molecules in the direct lethal action of miconazole against Candida albicans. Mycopathol 1988; 103: 91–94.

    Google Scholar 

  2. Beggs WH. Regulation of the direct fungicidal action of miconazole against Candida albicans ATCC 26790. Mycoses 1988; 31: 226–228.

    Google Scholar 

  3. Beggs WH, Hughes CE. Regulatory function of hydrogen ion on the direct lethal action of miconazole. J Antimicrob Chemother 1987; 20: 450–452.

    Google Scholar 

  4. Beggs WH, LaSota IR, Hughes CE. Antagonism of the direct fungicidal action of miconazole by miconazole fungistasis. Eur J clin Microbiol infect Dis 1988; 7: 413–414.

    Google Scholar 

  5. Cope JE. The interaction of 3H-miconazole with Candida albicans. Sabouraudia 1980; 18: 211–228.

    Google Scholar 

  6. Hitchcock CA, Barrett-Bee KJ, Russell NJ. The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. J gen Microbiol 1986; 132: 2421–2431.

    Google Scholar 

  7. Kerridge D. Mode of action of clinically important antifungal drugs. In: AH Rose and DW Tempest (eds) Advances in microbial physiology. Academic Press, London, Vol. 27, 1986, pp 1–72.

    Google Scholar 

  8. Sud IJ, Chou DL, Feingold DS. Effect of free fatty acids on liposome susceptibility to imidazole antifungals. Antimicrob Agents Chemother 1979; 16: 660–663.

    Google Scholar 

  9. Sud IJ, Feingold DS. Heterogeneity of action mechanisms among antimycotic imidazoles. Antimicrob Agents Chemother 1981; 20: 71–74.

    Google Scholar 

  10. Swamy KHS, Sirsi M, Rao GR. Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans. Antimicrob Agents Chemother 1974; 5: 420–425.

    Google Scholar 

  11. Vanden Bossche H, Willemsens G, Cools W, Lauwers WFJ, Le Jeune L. Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem Biol Interact 1978; 21: 59–78.

    Google Scholar 

  12. Vanden Bossche H, Willemsens G, Cools W, Marichal P, Lauwers W. Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles. Biochem Soc Trans 1983; 11: 665–667.

    Google Scholar 

  13. Yamaguchi H, Iwata K. Effect of fatty acyl group and sterol composition on sensitivity of lecithin liposomes to imidazole antimycotics. Antimicrob Agents Chemother 1979; 15: 706–711.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beggs, W.H. Development of phenotypic resistance to direct lethal miconazole action by Candida albicans entering stationary phase. Mycopathologia 108, 201–206 (1989). https://doi.org/10.1007/BF00436226

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00436226

Key words

Navigation